Starlight Cardiovascular focuses on creating medical devices specifically designed for infants with Congenital Heart Disease. The company develops a portfolio of specialized tools to address the unique anatomical challenges of pediatric cardiac care. This focus aims to improve treatment options for babies requiring cardiovascular intervention.
Funding
$9.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Infants with congenital heart disease require specialized medical devices tailored to their unique physiological needs, but the development and availability of such devices often lag behind those for adults. This disparity limits treatment options and can negatively impact surgical outcomes and post-operative care for these vulnerable patients.
Solution
Starlight Cardiovascular is developing a portfolio of medical devices specifically designed to address the unmet needs of infants with congenital heart disease. By focusing on this underserved population, the company aims to improve surgical outcomes and enhance the quality of life for affected children. Starlight Cardiovascular partners with various organizations and leverages expertise in pediatric device innovation to create targeted solutions for pediatric cardiac conditions.
Target Audience
The primary beneficiaries are infants born with congenital heart disease, as well as the surgeons and medical professionals who treat these conditions.
Features
- Development of novel medical devices tailored for infants with congenital heart disease
- Focus on improving surgical outcomes and post-operative care
- Collaboration with medical device accelerators and pediatric device consortia